Creative Medical Technology Holdings, Inc. (CELZ) vs Nuwellis, Inc. (NUWE)
A side-by-side comparison of Creative Medical Technology Holdings, Inc. and Nuwellis, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CELZ
Creative Medical Technology Holdings, Inc.
$0.90HealthcareDelayed quote: Oct 6, 2026, 11:32 AM EDT
NUWE
Nuwellis, Inc.
$0.72HealthcareDelayed quote: Oct 6, 2026, 11:33 AM EDT
Total return — CELZ vs NUWE
growth of $100 · dividends reinvested · last 8yCELZ -99.9% (-60.6%/yr)NUWE -100.0% (-87.7%/yr)CELZ compounded faster over this window
Log scale — wide-divergence pair
CELZ NUWE
CELZ vs NUWE: by the numbers
- •NUWE is the larger company ($3M vs $2M market cap).
- •Both run net losses; NUWE's is the smaller (-123.38% vs -201355.37% net margin).
- •NUWE grew revenue faster over the past five years (1.48% vs -50.85% CAGR).
Metrics side by side
Valuation
| Metric | CELZ | NUWE |
|---|---|---|
| P/S ratio | 777.64 | 0.29 |
| P/B ratio | 0.27 | N/A |
Profitability
| Metric | CELZ | NUWE |
|---|---|---|
| Gross margin | 63.43% | 69.69% |
| Operating margin | -102380.23% | -140.62% |
| Net margin | -201355.37% | -123.38% |
| ROE | -69.79% | N/A |
| ROIC | -71.90% | -238.32% |
Growth (annualized)
| Metric | CELZ | NUWE |
|---|---|---|
| Revenue CAGR (5Y) | -50.85% | 1.48% |
| Total return CAGR (5Y) | -57.96% | N/A |
Frequently asked
- Which has grown faster, CELZ or NUWE?
- Over the past five years, NUWE grew revenue faster — CELZ at a -50.85% CAGR versus NUWE at 1.48%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.